Skip to main content

Table 1 SSc patient and normal volunteer characteristics

From: Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis

  SSc patients Normal volunteers
Age (years) 52.5 ± 1.8a 51.2 ± 4.4
Women 18 3
Men 2 7
Diffuse SSc 19 NAb
Raynaud's 19 NA
Disease duration (years) 3.7 ± 0.8 NA
Early diseasec 13 NA
Late disease 7 NA
Deceased 4 NA
Renal involvement 1 NA
Interstitial lung disease 10 NA
Pulmonary arterial hypertension 2 NA
Digital ulcers 10 NA
Gastrointestinal disease 19 NA
Gastric antral vascular ectasia 3 NA
Immunomodulatory therapy 3 NA
SSc patients serum CXCL16 (ng/ml)
  With Without
Pulmonary arterial hypertension 5.7 ± 1.2 (n = 2)d 4.5 ± 0.1 (n = 18)
Early disease 4.9 ± 0.2 (n = 13)d 4.0 ± 0.1 (n = 7)
Deceased 5.6 ± 0.4 (n = 4)d 4.4 ± 0.1 (n = 16)
  1. aMean ± SEM. bNA = Not applicable. cEarly disease = less than five years. dP < 0.05.